menu search

AGLE / Aeglea Presents Itself As Buy Opportunity After Latest Data Causes Stock To Trade Lower

Aeglea achieved primary endpoint in reducing arginine levels with its drug pegzilarginase for ARG1-D, which in turn reduced ammonia in the blood plasma, by an average of 80%. BLA filing of pegzilarginase for patients with ARG1-D is expected to occur in 1st half of 2022. Read More
Posted: Dec 7 2021, 13:14
Author Name: Seeking Alpha
Views: 110513

AGLE News  

Best Penny Stocks To Watch? 4 Under $5 For Your List

By PennyStocks
July 12, 2023

Best Penny Stocks To Watch? 4 Under $5 For Your List

Are you looking for the best penny stocks to watch right now? With all of the excitement in the stock market today, you're not alone. more_horizontal

Top Penny Stocks To Buy? 3 To Watch Before Next Week

By PennyStocks
July 6, 2023

Top Penny Stocks To Buy? 3 To Watch Before Next Week

With the uptick of volatility in the stock market today, there's no question as to why penny stocks are red hot. Whether the broader markets are risk- more_horizontal

Best Penny Stocks To Buy? 4 To Watch Before July 4th

By PennyStocks
July 3, 2023

Best Penny Stocks To Buy? 4 To Watch Before July 4th

The Fourth of July Holiday in 2023 will see the stock market closed for a full session. But that doesn't mean fewer opportunities to make money in the more_horizontal

10 Top Penny Stocks To Watch Right Now For Under $1

By PennyStocks
June 29, 2023

10 Top Penny Stocks To Watch Right Now For Under $1

Welcome to the world of penny stocks. This is a corner of the stock market that piques interest and raises eyebrows in equal measure. more_horizontal

7 Penny Stocks To Watch Right Now For Under $1

By PennyStocks
June 27, 2023

7 Penny Stocks To Watch Right Now For Under $1

Have you ever dreamt of uncovering a hidden gem in the stock market, something that could turn your modest investment into a jackpot? Welcome to the w more_horizontal

Aeglea (AGLE) Soars 329% on Acquiring Spyre Therapeutics

By Zacks Investment Research
June 23, 2023

Aeglea (AGLE) Soars 329% on Acquiring Spyre Therapeutics

Aeglea's (AGLE) shares surge as it acquires Spyre Therapeutics, a private company that focuses on developing antibody therapeutics for inflammatory bo more_horizontal

Why Is Aeglea BioTherapeutics (AGLE) Stock Up 392% Today?

By InvestorPlace
June 22, 2023

Why Is Aeglea BioTherapeutics (AGLE) Stock Up 392% Today?

Aeglea BioTherapeutics (NASDAQ: AGLE ) stock is undergoing a massive rally on Thursday after it announced its acquisition of Spyre Therapeutics. Aegle more_horizontal

Best Penny Stocks to Buy Under $1? 10 To Watch Now

By PennyStocks
June 22, 2023

Best Penny Stocks to Buy Under $1? 10 To Watch Now

Stocks that are priced below $5 per share are typically referred to as penny stocks. However, for the purpose of this article, we will be focusing spe more_horizontal


Search within

Pages Search Results: